These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29266376)

  • 1. Bridging technology and clinical practice: innovating inpatient hyperglycaemia management in non-critical care settings.
    Thabit H; Hovorka R
    Diabet Med; 2018 Apr; 35(4):460-471. PubMed ID: 29266376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose control in non-critically ill inpatients with diabetes: towards closed-loop.
    Thabit H; Hovorka R
    Diabetes Obes Metab; 2014 Jun; 16(6):500-9. PubMed ID: 24267153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closed-loop management of inpatient hyperglycaemia.
    Boughton CK; Hovorka R
    Br J Hosp Med (Lond); 2019 Nov; 80(11):665-669. PubMed ID: 31707881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucometric benchmarking in an Australian hospital enabled by networked glucose meter technology.
    Kyi M; Colman PG; Rowan LM; Marley KA; Wraight PR; Fourlanos S
    Med J Aust; 2019 Aug; 211(4):175-180. PubMed ID: 31231826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current management of diabetes mellitus and future directions in care.
    Chatterjee S; Davies MJ
    Postgrad Med J; 2015 Nov; 91(1081):612-21. PubMed ID: 26453594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technology in the management of diabetes in hospitalised adults.
    Thabit H; Schofield J
    Diabetologia; 2024 Jul; ():. PubMed ID: 38953925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of diabetes and hyperglycaemia in the hospital.
    Pasquel FJ; Lansang MC; Dhatariya K; Umpierrez GE
    Lancet Diabetes Endocrinol; 2021 Mar; 9(3):174-188. PubMed ID: 33515493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose alert system improves health professional responses to adverse glycaemia and reduces the number of hyperglycaemic episodes in non-critical care inpatients.
    Kyi M; Wraight PR; Rowan LM; Marley KA; Colman PG; Fourlanos S
    Diabet Med; 2018 Jun; 35(6):816-823. PubMed ID: 29575134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus evidence-based guidelines for in-patient management of hyperglycaemia in non-critical care setting as per Indian clinical practice.
    Gangopadhyay KK; Bantwal G; Talwalkar PG; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):6-15. PubMed ID: 25668932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Continuous Glucose Monitoring in Non-ICU Hospital Settings for People With Diabetes: A Scoping Review of Emerging Benefits and Issues.
    Clubbs Coldron B; Coates V; Khamis A; MacRury S
    J Diabetes Sci Technol; 2023 Mar; 17(2):467-473. PubMed ID: 34696622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review.
    Farrington C
    Diabet Med; 2018 Apr; 35(4):436-449. PubMed ID: 29247547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes Technology in the Inpatient Setting for Management of Hyperglycemia.
    Davis GM; Galindo RJ; Migdal AL; Umpierrez GE
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):79-93. PubMed ID: 31980123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Type 1 diabetes technology pathway: consensus statement for the use of technology in Type 1 diabetes.
    Choudhary P; Campbell F; Joule N; Kar P;
    Diabet Med; 2019 May; 36(5):531-538. PubMed ID: 30773681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilisation, access and recommendations regarding technologies for people living with type 1 diabetes: consensus statement of the ADS/ADEA/APEG/ADIPS Working Group.
    Pease AJ; Andrikopoulos S; Abraham MB; Craig ME; Fenton B; Overland J; Price S; Simmons D; Ross GP
    Med J Aust; 2021 Nov; 215(10):473-478. PubMed ID: 34148253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing the Use of CGM Devices in a Non-ICU Setting.
    Wang M; Singh LG; Spanakis EK
    J Diabetes Sci Technol; 2019 Jul; 13(4):674-681. PubMed ID: 30636449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating optimal utilisation of technology in type 1 diabetes mellitus from a clinical and health economic perspective: protocol for a systematic review.
    Pease A; Lo C; Earnest A; Liew D; Zoungas S
    Syst Rev; 2018 Mar; 7(1):44. PubMed ID: 29530081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Type 1 Diabetes in the Hospital Setting.
    Mendez CE; Umpierrez GE
    Curr Diab Rep; 2017 Sep; 17(10):98. PubMed ID: 28913745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of raised glucose, a clinical decision tool to reduce length of stay of patients with hyperglycaemia.
    Herring R; Russell-Jones DL; Pengilley C; Hopkins H; Tuthill B; Wright J; Hordern SV; Davidson S
    Diabet Med; 2013 Jan; 30(1):81-7. PubMed ID: 22950637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.